✦ LIBER ✦

Olaparib: a promising PARP inhibitor in ovarian cancer therapy

✍ Scribed by Chen, Ying; Zhang, Lei; Hao, Quan

Book ID: 120713993
Publisher: Springer
Year: 2013
Tongue: English
Weight: 264 KB
Volume: 288
Category: Article
ISSN: 0003-9128
DOI: 10.1007/s00404-013-2856-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Olaparib, PARP1 inhibitor in ovarian can

Olaparib, PARP1 inhibitor in ovarian cancer

✍ Marchetti, Claudia; Imperiale, Ludovica; Gasparri, Maria Luisa; Palaia, Innocenz 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 271 KB

PARP inhibitors in ovarian cancer: Curre

PARP inhibitors in ovarian cancer: Current status and future promise

✍ Liu, Joyce F.; Konstantinopoulos, Panagiotis A.; Matulonis, Ursula A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 318 KB

PARP Inhibitors in Cancer Therapy: Promi

PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles

✍ Leif W. Ellisen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 321 KB

Olaparib Maintenance Therapy in Platinum

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

✍ Ledermann, Jonathan; Harter, Philipp; Gourley, Charlie; Friedlander, Michael; Ve 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 507 KB

Chemopotentiation by PARP inhibitors in

Chemopotentiation by PARP inhibitors in cancer therapy

✍ Lucio Tentori; Grazia Graziani 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 283 KB

PARP inhibitors in cancer therapy: an up

PARP inhibitors in cancer therapy: an update

✍ Papeo, Gianluca; Casale, Elena; Montagnoli, Alessia; Cirla, Alessandra 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 754 KB